Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-03-08 Sale |
2023-03-10 9:58 pm |
FIBROGEN INC | FGEN | Chung Christine SVP, China Operations |
15,960 | $20.7 | $330,357 | 259,050 (Direct) |
View |
| 2023-03-08 Sale |
2023-03-10 9:55 pm |
FIBROGEN INC | FGEN | Conterno Enrique A Chief Executive Officer |
56,261 | $20.62 | $1,159,971 | 412,668 (Indirect Direct) |
View |
| 2023-03-08 Sale |
2023-03-10 9:55 pm |
FIBROGEN INC | FGEN | Eisner Mark Chief Medical Officer |
17,503 | $20.6 | $360,572 | 175,176 (Direct) |
View |
| 2023-03-08 Sale |
2023-03-10 9:54 pm |
FIBROGEN INC | FGEN | Graham Juan Chief Financial Officer |
7,661 | $20.54 | $157,367 | 72,868 (Direct) |
View |
| 2023-03-08 Sale |
2023-03-10 9:53 pm |
FIBROGEN INC | FGEN | Wettig Thane Chief Commercial Officer |
13,934 | $20.63 | $287,435 | 111,558 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-06 4:59 pm |
FIBROGEN INC | FGEN | Eisner Mark Chief Medical Officer |
1,187 | $21.87 | $25,960 | 172,496 (Direct) |
View |
| 2023-01-06 Sale |
2023-01-10 4:46 pm |
FIBROGEN INC | FGEN | Conterno Enrique A Chief Executive Officer |
1,538 | $19.95 | $30,683 | 323,283 (Indirect Direct) |
View |
| 2022-12-08 Sale(A) |
2023-01-04 6:35 pm |
FIBROGEN INC | FGEN | Chung Christine SVP, China Operations |
2,595 | $15.79 | $40,975 | 234,873 (Direct) |
View |
| 2022-12-23 Sale |
2022-12-28 6:38 pm |
FIBROGEN INC | FGEN | Wettig Thane Chief Commercial Officer |
734 | $15.8 | $11,597 | 89,163 (Direct) |
View |
| 2022-12-09 Sale(A) |
2022-12-15 5:23 pm |
FIBROGEN INC | FGEN | Graham Juan Chief Financial Officer |
2,188 | $14.64 | $32,031 | 47,962 (Direct) |
View |
| 2022-12-08 Sale |
2022-12-15 5:23 pm |
FIBROGEN INC | FGEN | Graham Juan Chief Financial Officer |
5,741 | $14.89 | $85,498 | 50,150 (Direct) |
View |
| 2022-12-09 Sale |
2022-12-14 9:55 pm |
FIBROGEN INC | FGEN | Graham Juan Chief Financial Officer |
2,188 | $14.64 | $32,038 | 53,703 (Direct) |
View |
| 2022-12-08 Sale |
2022-12-09 7:22 pm |
FIBROGEN INC | FGEN | Chung Christine SVP, China Operations |
1,096 | $15.79 | $17,306 | 237,705 (Direct) |
View |
| 2022-12-08 Sale |
2022-12-09 7:21 pm |
FIBROGEN INC | FGEN | Wettig Thane Chief Commercial Officer |
382 | $15.79 | $6,032 | 89,897 (Direct) |
View |
| 2022-12-08 Sale |
2022-12-09 7:19 pm |
FIBROGEN INC | FGEN | Conterno Enrique A Chief Executive Officer |
2,543 | $15.79 | $40,154 | 324,820 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-03-08 Option Award |
2023-03-10 9:58 pm |
N/A N/A |
FIBROGEN INC | FGEN | Chung Christine SVP, China Operations |
15,137 | $0 | 259,050 (Direct) |
View |
| 2023-03-08 Option Award |
2023-03-10 9:55 pm |
N/A N/A |
FIBROGEN INC | FGEN | Conterno Enrique A Chief Executive Officer |
60,349 | $0 | 412,668 (Direct) |
View |
| 2023-03-08 Option Award |
2023-03-10 9:55 pm |
N/A N/A |
FIBROGEN INC | FGEN | Eisner Mark Chief Medical Officer |
20,183 | $0 | 175,176 (Direct) |
View |
| 2023-03-08 Option Award |
2023-03-10 9:54 pm |
N/A N/A |
FIBROGEN INC | FGEN | Graham Juan Chief Financial Officer |
7,567 | $0 | 72,868 (Direct) |
View |
| 2023-03-08 Option Award |
2023-03-10 9:53 pm |
N/A N/A |
FIBROGEN INC | FGEN | Wettig Thane Chief Commercial Officer |
15,137 | $0 | 111,558 (Direct) |
View |
| 2023-02-21 Option Award |
2023-02-23 8:42 pm |
N/A 2033-02-20 |
FIBROGEN INC | FGEN | Wettig Thane Chief Commercial Officer |
67,000 | $0 | 152,355 (Direct) |
View |
| 2023-02-21 Option Award |
2023-02-23 8:41 pm |
N/A 2033-02-20 |
FIBROGEN INC | FGEN | Graham Juan Chief Financial Officer |
67,000 | $0 | 114,962 (Direct) |
View |
| 2023-02-21 Option Award |
2023-02-23 8:39 pm |
N/A 2033-02-20 |
FIBROGEN INC | FGEN | Chung Christine SVP, China Operations |
67,000 | $0 | 301,873 (Direct) |
View |
| 2023-02-21 Option Award |
2023-02-23 8:38 pm |
N/A 2033-02-20 |
FIBROGEN INC | FGEN | Eisner Mark Chief Medical Officer |
87,500 | $0 | 228,683 (Direct) |
View |
| 2023-02-21 Option Award |
2023-02-23 8:29 pm |
N/A 2033-02-20 |
FIBROGEN INC | FGEN | Conterno Enrique A Chief Executive Officer |
228,400 | $0 | 551,683 (Direct) |
View |
| 2022-05-25 Ownership(A) |
2023-02-17 5:26 pm |
N/A N/A |
FIBROGEN INC | FGEN | Wettig Thane Chief Commercial Officer |
3,808 | $0 | 85,355 (Direct) |
View |
| 2022-05-25 Ownership |
2023-02-02 5:22 pm |
N/A N/A |
FIBROGEN INC | FGEN | Wettig Thane Chief Commercial Officer |
1,988 | $0 | 87,175 (Direct) |
View |
| 2022-09-06 Tax Withholding(A) |
2023-01-04 6:33 pm |
N/A N/A |
FIBROGEN INC | FGEN | Chung Christine SVP, China Operations |
1,851 | $12.26 | 242,151 (Direct) |
View |
| 2022-12-01 Tax Withholding |
2022-12-02 5:41 pm |
N/A N/A |
FIBROGEN INC | FGEN | Eisner Mark Chief Medical Officer |
1,084 | $15.04 | 141,183 (Direct) |
View |
| 2022-10-06 Tax Withholding |
2022-10-11 5:06 pm |
N/A N/A |
FIBROGEN INC | FGEN | Conterno Enrique A Chief Executive Officer |
1,296 | $14.26 | 327,363 (Direct) |
View |
| 2022-09-30 Tax Withholding |
2022-10-04 5:30 pm |
N/A N/A |
FIBROGEN INC | FGEN | Chung Christine SVP, China Operations |
4,683 | $13.01 | 238,801 (Direct) |
View |
| 2022-09-30 Tax Withholding |
2022-10-04 5:21 pm |
N/A N/A |
FIBROGEN INC | FGEN | Eisner Mark Chief Medical Officer |
6,777 | $13.01 | 142,267 (Direct) |
View |
| 2022-09-22 Tax Withholding |
2022-09-26 4:27 pm |
N/A N/A |
FIBROGEN INC | FGEN | Wettig Thane Chief Commercial Officer |
655 | $12.26 | 90,279 (Direct) |
View |
| 2022-09-07 Tax Withholding |
2022-09-08 6:59 pm |
N/A N/A |
FIBROGEN INC | FGEN | Graham Juan Chief Financial Officer |
3,009 | $12.62 | 55,891 (Direct) |
View |
| 2022-09-06 Tax Withholding |
2022-09-08 6:57 pm |
N/A N/A |
FIBROGEN INC | FGEN | Chung Christine SVP, China Operations |
518 | $12.26 | 243,484 (Direct) |
View |
| 2022-09-06 Tax Withholding |
2022-09-08 6:54 pm |
N/A N/A |
FIBROGEN INC | FGEN | Wettig Thane Chief Commercial Officer |
360 | $12.26 | 90,934 (Direct) |
View |
| 2022-09-06 Tax Withholding |
2022-09-08 6:53 pm |
N/A N/A |
FIBROGEN INC | FGEN | Conterno Enrique A Chief Executive Officer |
1,772 | $12.26 | 328,659 (Direct) |
View |
| 2022-09-01 Tax Withholding |
2022-09-02 5:30 pm |
N/A N/A |
FIBROGEN INC | FGEN | Eisner Mark Chief Medical Officer |
756 | $13.09 | 149,044 (Direct) |
View |
| 2022-07-06 Tax Withholding |
2022-07-08 4:42 pm |
N/A N/A |
FIBROGEN INC | FGEN | Conterno Enrique A Chief Executive Officer |
1,296 | $12.4 | 330,431 (Direct) |
View |
| 2022-06-22 Tax Withholding |
2022-06-24 5:27 pm |
N/A N/A |
FIBROGEN INC | FGEN | Wettig Thane Chief Commercial Officer |
655 | $11.42 | 91,294 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-21 9:13 pm |
N/A 2032-06-15 |
FIBROGEN INC | FGEN | Ho Maykin Director |
41,461 | $0 | 57,416 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-21 9:12 pm |
N/A 2032-06-15 |
FIBROGEN INC | FGEN | Henderson Jeffrey William Director |
41,461 | $0 | 59,261 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-21 9:10 pm |
N/A 2032-06-15 |
FIBROGEN INC | FGEN | EDWARDS JEFFREY L Director |
41,461 | $0 | 59,261 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-21 9:10 pm |
N/A 2032-06-15 |
FIBROGEN INC | FGEN | Cravatt Benjamin Director |
41,461 | $0 | 50,075 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-21 9:08 pm |
N/A 2032-06-15 |
FIBROGEN INC | FGEN | Brennan Aoife Director |
41,461 | $0 | 50,075 (Direct) |
View |